Toni Vidal-Puig TVP Lab

Toni Vidal-Puig TVP Lab

Give online
to Toni Vidal-Puig TVP Lab

  • Syringe with vial

Obesity rates are continuing to rise worldwide and it is inevitable that associated illnesses, such as liver disease and diabetes will follow the same trend unless new therapeutic approaches are developed.

Our programme of research explores the molecular mechanisms involved in controlling energy expenditure and fat deposition. Every day we move closer to understanding the complex processes driving human disease and closer to developing new treatments.

Find out more

Toni Vidal-Puig TVP Lab website

Gift announcements

Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.

Gift announcement
LycaHealth, the new healthcare brand, have presented a donation of £150,000 to Cambridge University to support Sri Lankan students and improve public health in Sri Lanka.   
Gift announcement
Multi-million pound legacy to create a new 'Ray and Dagmar Dolby Court' at Pembroke College

Related impact stories

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students received an unrivalled education.

Fatty deposits on the liver
Philanthropic impact story
Dr Jules Griffin’s research seeks to understand and combat factors that contribute to obesity and fatty liver disease.
The new Laboratory of Molecular Biology at Addenbrooke's hospital
Philanthropic impact story
At any one time, more than 1000 clinical trials are being conducted across the Cambridge Biomedical Campus, the largest gathering of clinical, pharmaceutical and biomedical research specialists in Europe. These trials are a crucial step in the design of new medicines and medical devices – translating ideas that started in a research laboratory into new treatments for patients.